Tag: Trial

Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...

Dow Jones futures fell ahead of the consumer price index inflation report, causing market sentiment to be cautious. Investors are ...

Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...

AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...

Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...

Babcock & Wilcox secures $13 million contract to provide environmental equipment to a North American petroleum refinery. The deal includes ...

Mining giant Glencore plans to sell its stake in the Koniambo Nickel venture due to mounting losses from falling nickel ...

Foodstuffs North Island is trialing facial recognition technology to combat retail crime in New Zealand. The six-month trial will assess ...

Stock futures dip as S&P 500 hits another record high. Diamondback Energy considers merger, Microsoft surpasses Apple in market cap, ...

Citi raises its price target on Generac Holdings, a leading power generation equipment manufacturer, to $128. However, they maintain a ...